Eric C. Andersen - 14 Aug 2023 Form 4 Insider Report for Vertex, Inc. (VERX)

Role
Director
Signature
/s/ Lisa Coleman, Attorney-in-Fact
Issuer symbol
VERX
Transactions as of
14 Aug 2023
Net transactions value
-$294,908
Form type
4
Filing time
16 Aug 2023, 16:03:22 UTC
Previous filing
15 Jun 2023
Next filing
22 Nov 2023

Quoteable Key Fact

"Eric C. Andersen filed Form 4 for Vertex, Inc. (VERX) on 16 Aug 2023."

Quick Takeaways

  • This page summarizes Eric C. Andersen's Form 4 filing for Vertex, Inc. (VERX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 16 Aug 2023, 16:03.

What Changed

  • Previous filing in this sequence was filed on 15 Jun 2023.
  • Current net transaction value: -$294,908.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERX Class A Common Stock Sale $294,908 -15,121 -13% $19.50 97,309 14 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.41 to $19.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .